No Data
GoodRx Holdings: Strong Business Fundamentals and Undervalued Potential Justify Buy Rating Despite CFO Transition
BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Cuts Target Price to $4.25
GoodRx CFO Karsten Voermann Steps Down, Interim Replacement Named -- Shares Fall
Express News | GoodRx Holdings Inc - Karsten Voermann Resigns as CFO of GoodRx Effective Jan 17, 2025
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
Citi Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $6.25